Three experts discuss the increased mortality risk for patients with diabetic retinopathy, available screening tools, and counseling patients during eye exams.
In this Healio Video Perspective from Retina 2025, Peter K. Kaiser, MD, of Ocular Therapeutix, discusses positive data for ...
Data from various retinal clinical trials suggest that there is a difference in efficacy in anti-VEGF therapies for patients ...
The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was well tolerated.
The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...
Insurance coverage for intravitreal injections, an essential treatment for diabetic retinopathy, depends on the specific terms and conditions of an individual’s health insurance policy.
( MENAFN - Mid-East Info) Dubai, United Arab Emirates, January 2025: The Retina clinic London will showcase cutting-edge ...
The implementation of AIDRSS offers transformative implications for DR screening in India, particularly in rural and ...
Experiencing fatigue, blurred vision, and unexplained weight loss, a young man sought medical consultation and was informed ...
Diabetes extends far beyond blood sugar management, affecting vital organs throughout the body. This chronic condition, affecting millions globally, requires ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback